Policy and regulations in light of the human body as a ‘superorganism’ containing multiple, intertwined symbiotic relationships

References

• Raison CL, Lowry CA, Rook GW. Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry 2010;67:1211–24.
   PubMed Web of Science ®Google Scholar
• Rook GA, Raison CL, Lowry CA. Microbial 'old friends', immunoregulation and socioeconomic status. Clinical & Experimental Immunology 2014;177:1–12.
   PubMed Web of Science ®Google Scholar
• Parker W, Ollerton J. Evolutionary biology and anthropology suggest biome reconstitution as a necessary approach toward dealing with immune disorders. Evolution, Medicine, and Public Health 2013;2013:89–103.
   PubMedGoogle Scholar
• Bilbo SD, Nevison CD, Parker W. A model for the induction of autism in the ecosystem of the human body: the anatomy of a modern pandemic? Microbial Ecology in Health & Disease 2015;26:26253.
   PubMedGoogle Scholar
• David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014;505:559–63.
   PubMed Web of Science ®Google Scholar
• Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222–7.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009;1:6ra14.
   PubMed Web of Science ®Google Scholar
• Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431–55.
   PubMed Web of Science ®Google Scholar
• Tillotson GS, Tillotson J. Susceptibility-testing criteria. The Lancet Infectious Diseases 2011;11:584.
   PubMed Web of Science ®Google Scholar
• Walters PR, Zuckerbraun BS. Clostridium difficile infection: clinical challenges and management strategies. Critical Care Nurse 2014;34:24–34; quiz 35.
   PubMed Web of Science ®Google Scholar
• Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. New England Journal of Medicine 2015;372:825–34.
   PubMed Web of Science ®Google Scholar
• Lessa FC, Gould CV, McDonald LC. Current status of Clostridium difficile infection epidemiology. Clinical Infectious Diseases 2012;55(Suppl 2):S65–S70.
   PubMed Web of Science ®Google Scholar
• Burckhardt F, Friedrich A, Beier D, Eckmanns T. Clostridium difficile surveillance trends, Saxony, Germany. Emerging Infectious Diseases 2008;14:691–2.
   PubMed Web of Science ®Google Scholar
• He M, Miyajima F, Roberts P, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 2013;45:109–113.
   PubMed Web of Science ®Google Scholar
• Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clinical Infectious Diseases 2003;36:580–5.
   PubMed Web of Science ®Google Scholar
• Backhed F, Ley RE, Sonnenburg JL, et al. Host-bacterial mutualism in the human intestine. Science 2005;307:1915–20.
   PubMed Web of Science ®Google Scholar
• Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958;44:854–9.
   PubMed Web of Science ®Google Scholar
• Collins DC. Pseudomembranous enterocolitis. Further observations on the value of donor fecal enemata as an adjunct in the treatment of pseudomembranous enterocolitis. American Journal of Proctology 1960;2:389–91.
   PubMedGoogle Scholar
• George RH, Symonds JM, Dimock F, et al. Identification of Clostridium difficile as a cause of pseudomembranous colitis. British Medical Journal 1978;1:695.
   PubMed Web of Science ®Google Scholar
• Schwan A, Sjolin S, Trottestam U, Aronsson B. Relapsing clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983;2:845.
   PubMed Web of Science ®Google Scholar
• Duke PS, Fardy J. Recurrent Clostridium difficile infection treated with home fecal transplantation: a case report. Journal of Medical Case Reports [Electronic Resource] 2014;8:393.
   PubMedGoogle Scholar
• Kassam Z, Hundal R, Marshall JK, Lee CH. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Archives of Internal Medicine 2012;172:191–3.
   PubMed Web of Science ®Google Scholar
• van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. New England Journal of Medicine 2013;368:407–15.
   PubMed Web of Science ®Google Scholar
• Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. American Journal of Gastroenterology 2014;109:1065–71.
   PubMed Web of Science ®Google Scholar
• Garborg K, Waagsbo B, Stallemo A. Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scandinavian Journal of Infectious Diseases 2010;42:857–61.
   PubMed Web of Science ®Google Scholar
• Khan MA, Sofi AA, Ahmad U, et al. Efficacy and safety of, and patient satisfaction with, colonoscopic-administered fecal microbiota transplantation in relapsing and refractory community- and hospital-acquired Clostridium difficile infection. Canadian Journal of Gastroenterology & Hepatology 2014;28:434–8.
   PubMed Web of Science ®Google Scholar
• Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. American Journal of Gastroenterology 2013;108:500–8.
   PubMed Web of Science ®Google Scholar
• Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA 2015;313:398–408.
   PubMed Web of Science ®Google Scholar
• Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clinical Infectious Diseases 2011;53:994–1002.
   PubMed Web of Science ®Google Scholar
• Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010;44:354–60.
   PubMed Web of Science ®Google Scholar
• Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012;107:761–7.
   PubMed Web of Science ®Google Scholar
• Bakken JS, Borody T, Brandt LJ, et al. Treating Clostridium difficile Infection With Fecal Microbiota Transplantation. Clinical Gastroenterology and Hepatology 2011;9:1044–1049.
   PubMed Web of Science ®Google Scholar
• Parker W, Perkins SE, Harker M, and Muehlenbein MP. A prescription for clinical immunology: the pills are available and ready for testing. Current Medical Research and Opinion 2012;28:1193–202.
   PubMed Web of Science ®Google Scholar
• Bilbo SD, Wray GA, Perkins SE, Parker W. Reconstitution of the human biome as the most reasonable solution for epidemics of allergic and autoimmune diseases. Medical Hypotheses 2011;77:494–504.
   PubMed Web of Science ®Google Scholar
• Cheng AM, Jaint D, Thomas S, et al. Overcoming evolutionary mismatch by self-treatment with helminths: current practices and experience. Journal of Evolutionary Medicine 2015;3:Article ID 235910.
   Google Scholar
• Bilbo SD, Jones JP, Parker W. Is autism a member of a family of diseases resulting from genetic/cultural mismatches? Implications for treatment and prevention. Autism Research and Treatment 2012;2012:1–11.
   Google Scholar
• Becker KG. Autism, asthma, inflammation, and the hygiene hypothesis. Medical Hypotheses 2007;69:731–740.
   PubMed Web of Science ®Google Scholar
• Rook GA, Raison CL, Lowry CA. Microbiota, immunoregulatory old friends and psychiatric disorders. Adv Exp Med Biol 2014;817:319–56.
   PubMed Web of Science ®Google Scholar
• Rook GA, Dalgleish A. Infection, immunoregulation, and cancer. Immunol Rev. 2011;240:141–59. doi: 10.1111/j.1600-065X.2010.00987.x.
   PubMed Web of Science ®Google Scholar
• León-Cabrera S, Callejas BE, Ledesma-Soto Y, et al. Extraintestinal Helminth Infection Reduces the Development of Colitis-Associated Tumorigenesis. International Journal of Biological Science 2014;10:948–956.
   PubMed Web of Science ®Google Scholar
• Cooper GS, Bynum ML, and Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. Journal of Autoimmunity 2009;33:197–207.
   PubMed Web of Science ®Google Scholar
• Simpson CR, Newton J, Hippisley-Cox J, Sheikh A. Incidence and prevalence of multiple allergic disorders recorded in a national primary care database. Journal of the Royal Society of Medicine 2008;101:558–63.
   PubMed Web of Science ®Google Scholar
• Forman D, Stockton D, Møller H, et al. Cancer prevalence in the UK: results from the EUROPREVAL study. Annals of Oncology 2003;14:648–654.
   PubMed Web of Science ®Google Scholar
• Genuis SJ. Sensitivity-related illness: the escalating pandemic of allergy, food intolerance and chemical sensitivity. Science of the Total Environment 2010;408:6047–61.
   PubMed Web of Science ®Google Scholar
• Arbes Jr SJ, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the Third National Health and Nutrition Examination Survey. Journal of Allergy and Clinical Immunology 2005;116:377–383.
   PubMed Web of Science ®Google Scholar
• Singh K, Axelrod S, Bielory L. The epidemiology of ocular and nasal allergy in the United States, 1988-1994. Journal of Allergy & Clinical Immunology 2010;126:778–783.e6.
   PubMed Web of Science ®Google Scholar
• Rook GAW. Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology 2009;126:3–11.
   PubMed Web of Science ®Google Scholar
• Jackson JA, Friberg IM, Little S, Bradley JE. Review series on helminths, immune modulation and the hygiene hypothesis: Immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies? Immunology 2009;126:18–27.
   PubMed Web of Science ®Google Scholar
• Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002;296:490–4.
   PubMed Web of Science ®Google Scholar
• Lukes J, Stensvold CR, Jirku-Pomajbikova K, Wegener Parfrey L. Are Human Intestinal Eukaryotes Beneficial or Commensals? PLoS Pathog 2015;11:e1005039.
   PubMed Web of Science ®Google Scholar
• Capron A, Dombrowicz D, Capron M. Helminth infections and allergic diseases. Clinical Reviews in Allergy and Immunology 2004;26:25–34.
   PubMed Web of Science ®Google Scholar
• Broadhurst MJ, Ardeshir A, Kanwar B, et al. Therapeutic helminth infection of macaques with idiopathic chronic diarrhea alters the inflammatory signature and mucosal microbiota of the colon. PLoS Pathog 2012;8:e1003000.
   PubMed Web of Science ®Google Scholar
• Turton JA. IgE, parasites, and allergy. Lancet 1976;2:686.
   PubMed Web of Science ®Google Scholar
• Summers RW, Elliott DE, Urban JF Jr, Thompson RA, and Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005;128:825–32.
   PubMed Web of Science ®Google Scholar
• Summers RW, Elliott DE, Urban JF Jr, Thompson R, and Weinstock JV. Trichuris suis therapy in Crohn's disease. Gut 2005;54:87–90.
   PubMed Web of Science ®Google Scholar
• Correale J, Farez M. Association between parasite infection and immune responses in multiple sclerosis. Annals of Neurology 2007;61:97–108.
   PubMed Web of Science ®Google Scholar
• Liu J, Morey RA, Wilson JK, Parker W. Practices and outcomes of self-treatment with helminths based on physicians' observations. Journal of Helminthology 2016;FirstView:1–11.
   Google Scholar
• Smith MB, Kelly C, Alm EJ. Policy: How to regulate faecal transplants. Nature 2014;506:290–1.
   PubMed Web of Science ®Google Scholar
• Eakin E. The Excrement Experiment, in The New Yorker. 2014:64–71.
   Google Scholar
• Correale J, Farez MF. The impact of parasite infections on the course of multiple sclerosis. Journal of Neuroimmunology 2011;233:6–11.
   PubMed Web of Science ®Google Scholar
• Lukes J, Kuchta R, Scholz T, Pomajbikova K. (Self-) infections with parasites: re-interpretations for the present. Trends in Parasitology 2014;30:377–85.
   PubMed Web of Science ®Google Scholar
• Falcone FH, Pritchard DI. Parasite role reversal: worms on trial. Trends in Parasitology 2005;21:157–60.
   PubMed Web of Science ®Google Scholar
• Rau ME. The frequency distribution of Hymenolepis diminuta cysticercoids in natural, sympatric populations of Tenebrio molitor and T. obscurus. International Journal for Parasitology 1979;9:85–87.
   Web of Science ®Google Scholar
• Wiwanitkit V. Overview of hymenolepis diminuta infection among Thai patients. MedGenMed 2004;6:7.
   PubMedGoogle Scholar
• Tena D, Perez Simon M, Gimeno C, et al. Human infection with Hymenolepis diminuta: case report from Spain. J Clin Microbiol 1998;36:2375–6.
   PubMed Web of Science ®Google Scholar
• Edelman MH, Spingarn CL, Nauenberg WG, Gregory C. Hymenolepis diminuta (rat tapeworm) infection in man. The American Journal of Medicine 1965;38:951–953.
   PubMed Web of Science ®Google Scholar
• Rohela M, Ngui R, Lim YA, et al. A case report of Hymenolepis diminuta infection in a Malaysian child. Trop Biomed 2012;29:224–30.
   PubMed Web of Science ®Google Scholar
• Patamia I, Cappello E, Castellano-Chiodo D, et al. A human case of Hymenolepis diminuta in a child from eastern Sicily. Korean J Parasitol 2010;48:167–9.
   PubMed Web of Science ®Google Scholar
• Watwe S, Dardi CK. Hymenolepis diminuta in a child from rural area. Indian J Pathol Microbiol 2008;51:149–50.
   PubMed Web of Science ®Google Scholar
• Surawicz CM, Alexander J. Treatment of refractory and recurrent Clostridium difficile infection. Nature Reviews Gastroenterology & Hepatology 2011;8:330–9.
   PubMed Web of Science ®Google Scholar
• Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. Journal of Infectious Diseases 2008;197:435–438.
   PubMed Web of Science ®Google Scholar
• Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nature Reviews Genetics 2012;13:260–70.
   PubMed Web of Science ®Google Scholar